News

PipelineReview.com3d
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to ...
Eli Lilly and Company: FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...
MedPage Today4d
Nearly Half of Teen Vapers Have Recently Tried to Quit
No nicotine replacement therapy is approved for youth, but the American Academy of Pediatrics recommends considering ...
WJTV5d
Public Service Loan Forgiveness could become Trump retribution tool, advocates fear
More than 1 million Americans have had loans canceled through the program, including nurses, college staffers and park ...
Trump is reshaping a student loan forgiveness program. Some fear politics will decide who qualifies
Organizations that serve immigrants and transgender youth could be ejected from a federal program that cancels student loans ...